20/20 Gene Systems
Anne Shiflett has a diverse and extensive work history in finance and administration roles. Anne has held positions such as Chief Financial Officer, VP of Finance & Administration, Business Advisor, and Chief Business Officer in various companies, including 20/20 GeneSystems, Gypsy Basin Genomics, Inc., and Catalent Pharma Solutions. Anne'sexperience includes working with venture-backed drug development companies, clinical pharmacology centers, and biotechnology firms.
Anne Shiflett earned a Bachelor of Business Administration (BBA) in Accounting from Loyola University Maryland in 1988. Anne then went on to complete a Master of Business Administration (MBA) in Finance and Entrepreneurial Services from Loyola in the same year.
This person is not in any offices
20/20 Gene Systems
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug